Cargando…

A retrospective study evaluating efficacy and safety of linagliptin in treatment of NODAT (in renal transplant recipients) in a real world setting

New-onset diabetes after transplantation (NODAT) is frequently encountered after kidney transplant. In the present study, we retrospectively evaluated the safety and efficacy of linagliptin monotherapy in 21 renal transplant recipients in a real world setting. We found linagliptin monotherapy is eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanyal, Debmalya, Gupta, Soumava, Das, Pratik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830305/ https://www.ncbi.nlm.nih.gov/pubmed/24251159 http://dx.doi.org/10.4103/2230-8210.119572

Ejemplares similares

Prevalence and Predictors of “New-onset Diabetes after Transplantation” (NODAT) in Renal Transplant Recipients: An Observational Study
por: Choudhury, Partha Sarathi, et al.
Publicado: (2019)

Low dose liraglutide in Indian patients with type 2 diabetes in the real world setting
por: Sanyal, Debmalya, et al.
Publicado: (2013)

Abstract 132: Incidence and predictors of new onset diabetes after transplant (NODAT) in liver transplant recipients
por: Sheth, Kaushal V, et al.
Publicado: (2022)

PSUN228 Incidence and Predictors of New Onset Diabetes After Transplant (NODAT) in Liver Transplant recipients.
por: Sheth, Kaushal, et al.
Publicado: (2022)

New onset diabetes after transplantation (NODAT): an overview
por: Pham, Phuong-Thu T, et al.
Publicado: (2011)

Remnant lipoprotein cholesterol is associated with incident new onset diabetes after transplantation (NODAT) in renal transplant recipients: results of the TransplantLines Biobank and cohort Studies
por: Szili-Torok, Tamas, et al.
Publicado: (2022)

New-Onset Diabetes After Renal Transplantation (NODAT): Is It a Risk Factor for Renal Cell Carcinoma or Renal Failure?
por: Nie, Haibo, et al.
Publicado: (2019)

Prevalence and Risk Factors of New-Onset Diabetes After Transplantation (NODAT)
por: Zielińska, Katarzyna, et al.
Publicado: (2020)

Hyperglycemia in the Posttransplant Period: NODAT vs Posttransplant Diabetes Mellitus
por: Gupta, Suruchi, et al.
Publicado: (2018)

An observational Prospective Study to Evaluate the Preoperative Risk Factors of New-onset Diabetes Mellitus after Renal Transplantation in a Tertiary Care Centre in Eastern India
por: Kumar, Santosh, et al.
Publicado: (2018)

New-onset Diabetes after Renal Transplantation – A Clinical Insight
por: Sanyal, Debmalya
Publicado: (2019)

Clinical and genetic risk factors for new-onset diabetes mellitus after transplantation (NODAT) in major transplant centres in Malaysia
por: Guad, Rhanye Mac, et al.
Publicado: (2020)

Self-Reported Real-World Safety and Reactogenicity of COVID-19 Vaccines: A Vaccine Recipient Survey
por: Mathioudakis, Alexander G., et al.
Publicado: (2021)

Opportunistic infections in a renal transplant recipient
por: Mysorekar, Vijaya V., et al.
Publicado: (2012)

Real-World Glycemic Lowering Effectiveness of Linagliptin Among Adults with Type 2 Diabetes by Age, Renal Function, and Race
por: Hoogwerf, Byron J., et al.
Publicado: (2020)

Risk factors for new-onset diabetes mellitus after kidney transplantation (NODAT): a Brazilian single center study
por: Lima, Camila, et al.
Publicado: (2018)

Comparison of Adverse Kidney Outcomes With Empagliflozin and Linagliptin Use in Patients With Type 2 Diabetic Patients in a Real-World Setting
por: Lee, Yueh-Ting, et al.
Publicado: (2021)

A case of simultaneous occurrence of Graves’ disease and Hashimoto's thyroiditis
por: Majumder, Anirban, et al.
Publicado: (2012)

Outcome in acromegaly: A retrospective analysis
por: Sanyal, Debmalya, et al.
Publicado: (2012)

Infants with dilated cardiomyopathy and hypocalcemia
por: Sanyal, Debmalya, et al.
Publicado: (2013)

Primary adrenal insufficiency in case of antiphospholipid syndrome
por: Sanyal, Debmalya, et al.
Publicado: (2013)

Advanced Diabetic Nephropathy with “Clean” Eyes: An Extreme Phenotype
por: Sanyal, Debmalya, et al.
Publicado: (2018)

Real-world Accuracy of CGM in Inpatient Critical and Noncritical Care Settings at a Safety-Net Hospital
por: Finn, Erin, et al.
Publicado: (2023)

Parathyroid hormone in renal transplanted recipients; a single center study
por: Nasri, Hamid, et al.
Publicado: (2013)

Use of Linagliptin for the Management of Medicine Department Inpatients with Type 2 Diabetes in Real-World Clinical Practice (Lina-Real-World Study)
por: Pérez-Belmonte, Luis M., et al.
Publicado: (2018)

Three cases of thyrotoxic periodic paralysis due to painless thyroiditis
por: Sanyal, Debmalya, et al.
Publicado: (2013)

Tuberculosis in renal transplant recipients
por: Sundaram, Madhivanan, et al.
Publicado: (2008)

Abstract #1003971: Efficacy and Safety of Empagliflozin and Linagliptin Combination in Non-hospitalized COVID-19 Positive Patients with T2DM in Real World Setting: A Single Center Retrospective Study
por: Bhattacharya, Supratik
Publicado: (2021)

Real-world insights from launching remote peer-to-peer mentoring in a safety net healthcare delivery setting
por: Lyles, Courtney R, et al.
Publicado: (2020)

Extensive Ureteral Stricture in Renal Transplant Recipients: Prevalence and Impact on Graft and Patient Survival
por: Mahdavi Zafarghandi, R., et al.
Publicado: (2013)

The Reasons of Renal Transplant Recipients’ Admission to the Emergency Department; a Case Series Study
por: Uysal, Erdal, et al.
Publicado: (2016)

Postoperative association between impaired renal function and vascular dysfunction in liver transplant recipients
por: Chavez, Domenico A., et al.
Publicado: (2023)

Pregnancy in renal transplantation: Recipient and donor aspects in the Arab world
por: Kukla, Aleksandra, et al.
Publicado: (2012)

Safety of Probiotics Among High-Risk Pediatric Hematopoietic Stem Cell Transplant Recipients
por: Sadanand, Arhanti, et al.
Publicado: (2019)

Teneligliptin real-world efficacy assessment of type 2 diabetes mellitus patients in India (TREAT-INDIA study)
por: Ghosh, Sujoy, et al.
Publicado: (2016)

Hyperhomocysteinaemia in liver transplant recipients
por: Nkansa-Dwamema, David, et al.
Publicado: (2004)

Kidney Transplantation From Hepatitis C Viremic Deceased Donors to Aviremic Recipients in a Real-world Setting
por: Concepcion, Beatrice P., et al.
Publicado: (2021)

Juvenile hypothyroidism presenting with hypertrichosis, multicystic ovaries, and pituitary adenoma
por: Raychaudhuri, Moutusi, et al.
Publicado: (2013)

Linagliptin: farmacology, efficacy and safety in type 2 diabetes treatment
por: Guedes, Erika Paniago, et al.
Publicado: (2013)

Real-world Efficacy and Safety of Apremilast Monotherapy in the Management of Moderate-to-severe Psoriasis
por: Shah, Bela J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jif8vdhsmvmflknumqud3j058e